CD86 and Huntington disease: Concerning the co-stimulatory potential of CD21low B cells, flow cytometric analysis revealed that the expression of the co-stimulatory molecules CD80 and CD86 was increased on all CD21low B-cell populations when compared to the respective CD21pos population of HD (Figure 1C).